venetoclax,actimab
abbvie,roche,actinium pharma
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'venetoclax']
actinium highlights survival data in relapsed/refractory aml patients with prior venetoclax treatment and/or with a tp53 mutation from the actimab-a clag-m combination trial oral presentation at ash. read more: $atnm #ash22
Actinium is developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently investigating therapies in #AML #BMT $ATNM